StockData

Medifast vs WW International

MED and WW side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How MED and WW compare

Medifast is the larger company, worth 1.4 times as much as WW International ($145M against $104M).

Medifast scores higher on the StockData Score (10 against 3 for WW International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricMEDWW
Size and price
Market cap$145M$104M
Share price$12.97$10.37
Change, 1 year11.5%−62.7%
Change, 5 years−94.1%−99.4%
Beta (5Y)0.711.74
Employees3803,500
StockData Score
Total score10 (better)3
Valuation score3 (better)1
Growth score11
Performance score00
Health score6 (better)1
Dividend score00
Valuation
P/S0.5×–
P/B0.8×0.4× (better)
FCF yield−2.7%–
Fair value$35.80–
Margin of safety63.8%–
Growth
Revenue growth (TTM)−30.3%–
Revenue growth, 5Y average−16.2%–
Net income growth (TTM)−16573%–
EPS growth (TTM)−37000%–
Profitability
Gross margin69.2%–
Operating margin−11.6%–
Net margin−13.6%–
FCF margin−1.3%–
Return on equity−20.7%–
Return on invested capital−110%–
Financial health
Debt / equity0.001.45 (better)
Current ratio4.82 (better)1.75
Altman Z-score3.83 (better)0.07
Piotroski F-score4–
Dividends and buybacks
Dividend yield0.00%–
Years of dividend growth0–
Shareholder yield0.00%0.00%
Ownership
Held by institutions73.9%74.0%
Held by insiders12.3%49.0%
Insider net buying, 12 months$1.5M (better)$919K
Short interest, % of float13.2%40.1%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.